corporate_strategy

Zimmer Biomet Names Three Presidents in Americas Restructuring

Image
Zimmer Biomet Names Three Presidents in Americas Restructuring

Warsaw, Ind. – September 12, 2026 -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) named three internal executives to newly restructured president roles effective October 1, as Group President Kevin Thornal exits the company on September 30 following a transition period.

Gary Campbell takes over commercial strategy across the Americas

Campbell, promoted to President, Americas, will oversee commercial execution in the United States, Canada and Latin America. He has served as vice president and general manager, Orthopedics – North America, since September 2024, and joined Zimmer Biomet in 2019 after prior sales and marketing roles at Enovis.

Genpact Names Sumita Pandit CFO, Succeeding Michael Weiner

Image
Genpact Names Sumita Pandit CFO, Succeeding Michael Weiner

New York – September 11, 2026 -- Genpact (NYSE: G) has appointed Sumita Pandit as Senior Vice President and Chief Financial Officer, effective September 9, 2026, placing a 25-year finance and capital markets veteran at the helm of its balance sheet as the company pushes its Agentic Operations strategy.

Pandit succeeds Michael Weiner, who exits after five years as CFO

Pandit takes over from Michael Weiner, who has held the CFO post since 2021 and will remain with Genpact as an advisor through the end of Q1 2027 to support the transition. She will report directly to President and CEO Balkrishan 'BK' Kalra and join the Genpact Leadership Council.

Kalra credited Weiner with strengthening Genpact's financial foundation over the past five years and positioning the company for its next growth phase.

Danone Names Krummenacher DACH General Manager From November 2026

Image
Danone Names Krummenacher DACH General Manager From November 2026

Frankfurt – September 09, 2026 -- Danone has appointed Jean-Yves Krummenacher as General Manager for Germany, Austria and Switzerland (DACH), effective November 2026, succeeding Richard Trechman, who is leaving the company for an external role.

Krummenacher brings 25 years of internal Danone experience to the DACH post

The Swiss and French national most recently served as Global Chief Procurement Officer, overseeing Danone's worldwide procurement strategy while also managing the company's global trading and sourcing business as its chief executive. Earlier in his career he held leadership roles across Europe, Asia and Latin America spanning sales, procurement and sustainability functions.

Multiconsult, Rejlers to Merge Into SEK 8 Billion Nordic Consultancy

Stockholm and Oslo – September 09, 2026 -- Multiconsult ASA and Rejlers AB have agreed to merge into a combined pan-Nordic consultancy group with close to 8,000 employees and a market capitalisation of nearly SEK 8 billion.

Boards approve merger of equals with 54-46 ownership split

Under the joint cross-border merger plan adopted by both boards, each Multiconsult shareholder will receive 0.9725 Rejlers class B shares per share held, giving Multiconsult shareholders 54% and Rejlers shareholders 46% of the new entity. The combined company will be named Multiconsult Rejlers and will be dual listed on Nasdaq Stockholm and Euronext Oslo Børs.

BRP Names Minh Thanh Tran CFO as Sébastien Martel Retires

Image
BRP Names Minh Thanh Tran CFO as Sébastien Martel Retires

Valcourt, QC – September 08, 2026 -- BRP Inc. (TSX: DOO) (NASDAQ: DOO) will install Minh Thanh Tran as Chief Financial Officer effective October 1, 2026, succeeding Sébastien Martel, who is retiring after more than 20 years with the powersports manufacturer.

Martel exits after 12 years steering BRP's finances

Martel, who has served as CFO for 12 years, led the company's initial public offering on the Toronto Stock Exchange in 2013 -- named IPO of the Year -- and its subsequent NASDAQ listing in 2018. He will shift to a role as Executive Advisor to the CEO starting October 1, 2026, supporting a transition period before his full retirement in April 2027.

AdEx Partners Merges BMC Strategy Consultants Into New AdEx Strategy Brand

Image
AdEx Partners Merges BMC Strategy Consultants Into New AdEx Strategy Brand

Munich – September 07, 2026 -- AdEx Partners has completed the legal merger of BMC Strategy Consultants GmbH into AdEx Beratungs GmbH, effective August 25, 2026, relaunching the strategy unit under the new brand AdEx Strategy.

Merger creates single advisory platform spanning strategy, transformation and AI

The combined entity integrates strategic management consulting, transformation execution and applied AI into one continuous service line. AdEx Partners says the model is designed to stress-test decisions for feasibility early, keep transformation programs aligned to strategic goals, and deploy AI only where it delivers measurable value.

Lighteum Medical Names Gaurav Agarwal as New CEO

Image
Lighteum Medical Names Gaurav Agarwal as New CEO

San Diego – September 07, 2026 -- Lighteum Medical has appointed Gaurav Agarwal as Chief Executive Officer, effective August 31, 2026, bringing nearly 30 years of medtech leadership to the precision component manufacturer.

Agarwal joins with a track record of over $15 billion in M&A activity and $11 billion in private equity dispositions

Agarwal most recently served as President and CEO of PE-backed Capsa Healthcare, where he delivered more than 20% revenue and EBITDA growth within 18 months, completed two tuck-in acquisitions, and expanded the company into software and services. He previously led Vyaire Medical as President and CEO, and held senior roles at Acelity/KCI, Smith & Nephew, and GE Healthcare. At Acelity/KCI, he oversaw global commercial operations during a portfolio transformation that preceded the company's $6.725 billion sale to 3M.

Fosun International Profit Jumps 160.3% to RMB1.72 Billion in H1 2026

HONG KONG -- September 01, 2026 -- Fosun International reported a 160.3% year-on-year surge in first-half profit attributable to owners of the parent to RMB1.72 billion, the conglomerate said at an interim results presentation held in Hong Kong on Aug. 28. Total revenue for the six-month period reached RMB86.96 billion, with overseas markets contributing RMB49.16 billion, or 56.5% of the total. The briefing marked Fosun's first in-person results presentation in Hong Kong in six years, attended by Chairman Guo Guangchang, Co-Chairman Wang Qunbin, Co-CEOs Chen Qiyu and Xu Xiaoliang, and CFO Gong Ping.

Four Core Units Generate 73.5% of Group Revenue

Fosun Pharma, Yuyuan, Portuguese insurer Fidelidade, and the group's tourism segment together accounted for 73.5% of total revenue in the first half, the company disclosed. Pharmaceutical and insurance operations delivered the strongest performance among the four units.